Andrée R.
- Country
- Belgium
- Department
- Oncology
Research Overview
- A Phase 3, Randomized, Open-label, Study of Subcutaneous Nivolumab + Relatlimab Fixed-dose Combination versus Intravenous Nivolumab + Relatlimab Fixed-dose Combination in Participants with Previously Untreated Metastatic or Unresectable Melanoma
- Phase III Trial of BNT327 plus Combination Chemotherapy versus Placebo plus Chemotherapy in Patients with Previously Untreated Metastatic or Locally Recurrent Triple-Negative Breast Cancer
- Evaluation of Trastuzumab Deruxtecan in Unresectable/Metastatic HER2-low or HER2 IHC0 Breast Cancer: A Multicenter, Open-label Study
Data & Insights
Has run more than one trial at 252 of 491 partner sites.
Specializations
Breast Cancer Research
This investigator specializes in multiple breast cancer subtypes, with particular focus on hormone receptor-positive (HR+) and HER2-negative breast cancer treatments. Their research encompasses both early-stage and advanced disease states.
- Advanced/Metastatic Disease Management
- HER2-low Breast Cancer Therapies
- Triple Negative Breast Cancer Treatment
The investigator explores innovative therapeutic combinations including endocrine therapy and targeted treatments for breast cancer patients.
Melanoma Studies
The investigator conducts research in advanced melanoma treatment, focusing on both early-stage interventions and management of metastatic disease. Their work includes investigation of immunotherapy approaches.
- Stage III/IV Melanoma Treatment
- Adjuvant Therapy Development
- Immunotherapy Combinations
Their research extends to both resectable and unresectable melanoma cases, exploring novel therapeutic combinations.
Targeted Therapies
The investigator develops and evaluates targeted therapeutic approaches for various solid tumors, with special attention to HER2-altered cancers and immunotherapy applications.
- Novel Drug Combinations
- Personalized Treatment Approaches
- Biomarker-Driven Therapies
Research includes investigation of antibody-drug conjugates and targeted molecular therapies across multiple cancer types.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.